BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 11857296)

  • 1. Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel.
    Barozzi C; Ravaioli M; D'Errico A; Grazi GL; Poggioli G; Cavrini G; Mazziotti A; Grigioni WF
    Cancer; 2002 Feb; 94(3):647-57. PubMed ID: 11857296
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morphology Matters: A Critical Reappraisal of the Clinical Relevance of Morphologic Criteria From the 2019 WHO Classification in a Large Colorectal Cancer Cohort Comprising 1004 Cases.
    Jesinghaus M; Schmitt M; Lang C; Reiser M; Scheiter A; Konukiewitz B; Steiger K; Silva M; Tschurtschenthaler M; Lange S; Foersch S; Becker KF; Saur D; Friess H; Halfter K; Engel J; Boxberg M; Pfarr N; Wilhelm D; Weichert W
    Am J Surg Pathol; 2021 Jul; 45(7):969-978. PubMed ID: 34105518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Immune-Related and Inflammatory Markers and Their Prognostic Impact in Colorectal Cancer Patients.
    An S; Kim SK; Kwon HY; Kim CS; Bang HJ; Do H; Kim B; Kim K; Kim Y
    Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CINSARC signature outperforms gold-standard TNM staging and consensus molecular subtypes for clinical outcome in stage II-III colorectal carcinoma.
    Brunac AC; Fourquet J; Perot G; Jaffrelot M; Meilleroux J; Danjoux M; Filleron T; Nicolaï V; Guimbaud R; Icher S; Farés N; Selves J; Chibon F
    Mod Pathol; 2022 Dec; 35(12):2002-2010. PubMed ID: 36202996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Tumor Microenvironment in Liver Metastases from Colorectal Carcinoma in the Context of the Histologic Growth Patterns.
    Garcia-Vicién G; Mezheyeuski A; Bañuls M; Ruiz-Roig N; Molleví DG
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33546502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between metalloproteinase-9 (MMP-9) expression and clinicopathology in colorectal cancer: a cross-sectional study.
    Mudatsir ; Labeda I; Uwuratuw JA; Hendarto J; Warsinggih ; Lusikooy RE; Mappincara ; Sampetoding S; Kusuma MI; Syarifuddin E; Arsyad A; Faruk M
    Ann Med Surg (Lond); 2023 Sep; 85(9):4277-4282. PubMed ID: 37663709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased Glypican-3 immunostaining is associated with longer survival outcomes in colorectal carcinoma.
    Al-Maghrabi J; Al-Mansouri Z; Al-Harbi A; Assidi M; Buhmeida A; Gomaa W
    Pol J Pathol; 2022; 73(1):14-20. PubMed ID: 35848476
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HER-3 surface expression increases in advanced colorectal cancer representing a potential therapeutic target.
    Capone E; Tryggvason T; Cela I; Dufrusine B; Pinti M; Del Pizzo F; Gunnarsdottir HS; Grottola T; De Laurenzi V; Iacobelli S; Lattanzio R; Sala G
    Cell Death Discov; 2023 Oct; 9(1):400. PubMed ID: 37898642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In Vivo Staging the Progression of Colitis and Associated Cancer by Concurrent Microimaging of Key Biomarkers.
    Han Z; Li Y; Wang X; Li C; Li C; Lin Q; Xu E; Tang J; Lai M; Ma Y; Gu Y
    Anal Chem; 2023 Jul; 95(27):10298-10308. PubMed ID: 37366081
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiplex fluorescent immunohistochemistry quantitatively analyses microvascular density (MVD) and the roles of TGF-β signalling in orchestrating angiogenesis in colorectal cancer.
    Yang L; Liu Z; Wen T
    Transl Cancer Res; 2019 Apr; 8(2):429-438. PubMed ID: 35116775
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The tendency of segmental distribution of hepatic metastasis according to couinaud classification: a comparison of portal versus systemic route of metastatis due to primary colorectal and breast tumors.
    Khan D; Khan AK; Khan SD; Aman M; Amin A; Waseem M; Kumari U; Khan F; Pervez A; Khan A
    Ann Med Surg (Lond); 2023 Oct; 85(10):4806-4810. PubMed ID: 37811027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Twenty-year experience in liver surgery in metastatic colorectal patients: a case series study in Ukraine.
    Burlaka A; Ryzhov A; Ostapenko Y; Bankovska N; Kopchak K; Zvirych V; Golovko T; Shypko A; Lukashenko A
    Ann Med Surg (Lond); 2023 May; 85(5):1413-1419. PubMed ID: 37228969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trapping all ERBB ligands decreases pancreatic lesions in a murine model of pancreatic ductal adenocarcinoma.
    Hedegger K; Blutke A; Hommel T; Auer KE; Nataraj NB; Lindzen M; Yarden Y; Dahlhoff M
    Mol Oncol; 2023 Nov; 17(11):2415-2431. PubMed ID: 37341059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exercise and colorectal cancer: prevention and molecular mechanisms.
    Amirsasan R; Akbarzadeh M; Akbarzadeh S
    Cancer Cell Int; 2022 Aug; 22(1):247. PubMed ID: 35945569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Candidate Biomarkers and Prognostic Analysis in Colorectal Cancer Liver Metastases.
    Zhang T; Yuan K; Wang Y; Xu M; Cai S; Chen C; Ma J
    Front Oncol; 2021; 11():652354. PubMed ID: 34422629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer.
    Zaanan A; Calmel C; Henriques J; Svrcek M; Blons H; Desbois-Mouthon C; Merabtene F; Goumard C; Parc Y; Gayet B; Taieb J; Validire P; Louvet C; Fléjou JF; Le Bouc Y; Praz F
    Cell Oncol (Dordr); 2020 Apr; 43(2):237-247. PubMed ID: 31823290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin-Like Growth Factor 2 (IGF2) Signaling in Colorectal Cancer-From Basic Research to Potential Clinical Applications.
    Kasprzak A; Adamek A
    Int J Mol Sci; 2019 Oct; 20(19):. PubMed ID: 31623387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucocorticoid Receptor Modulates EGFR Feedback upon Acquisition of Resistance to Monoclonal Antibodies.
    Gelfo V; Pontis F; Mazzeschi M; Sgarzi M; Mazzarini M; Solmi R; D'Uva G; Lauriola M
    J Clin Med; 2019 May; 8(5):. PubMed ID: 31052457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beclin 1 and LC3 as predictive biomarkers for metastatic colorectal carcinoma.
    Zhao H; Yang M; Zhao B
    Oncotarget; 2017 Aug; 8(35):59058-59067. PubMed ID: 28938618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Significance of glycolytic metabolism-related protein expression in colorectal cancer, lymph node and hepatic metastasis.
    Martins SF; Amorim R; Viana-Pereira M; Pinheiro C; Costa RF; Silva P; Couto C; Alves S; Fernandes S; Vilaça S; Falcão J; Marques H; Pardal F; Rodrigues M; Preto A; Reis RM; Longatto-Filho A; Baltazar F
    BMC Cancer; 2016 Jul; 16():535. PubMed ID: 27460659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.